These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29154707)

  • 21. The Efficacy and Safety of Topical Rocuronium Bromide to Induce Bilateral Mydriasis in Hispaniolan Amazon Parrots ( Amazona ventralis ).
    Baine K; Hendrix DV; Kuhn SE; Souza MJ; Jones MP
    J Avian Med Surg; 2016 Mar; 30(1):8-13. PubMed ID: 27088739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice.
    Barathi VA; Beuerman RW; Schaeffel F
    Vision Res; 2009 Feb; 49(3):383-7. PubMed ID: 19059278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of topical 1% cyclopentolate hydrochloride on quantitative pupillometry measurements, tear production and intraocular pressure in healthy horses.
    Ortillés Á; Sanmartí J; Ríos J; Armengou L; Peña MT; Leiva M
    Vet Ophthalmol; 2020 Jul; 23(4):730-739. PubMed ID: 32519781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tegaserod (HTF 919) stimulates gut motility in normal horses.
    Lippold BS; Hildebrand J; Straub R
    Equine Vet J; 2004 Nov; 36(7):622-7. PubMed ID: 15581328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of continuous or intermittent lipopolysaccharide administration for 48 hours on the systemic inflammatory response in horses.
    Tadros EM; Frank N
    Am J Vet Res; 2012 Sep; 73(9):1394-402. PubMed ID: 22924721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of plasma ionized calcium levels and Ca2+ substitution response patterns as prognostic parameters for ileus and survival in colic horses.
    Delesalle C; Dewulf J; Lefebvre RA; Schuurkes JA; Van Vlierbergen B; Deprez P
    Vet Q; 2005 Dec; 27(4):157-72. PubMed ID: 16402513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equine piroplasmosis treatment protocols: specific effect on orocaecal transit time as measured by the lactose 13C-ureide breath test.
    Kutscha J; Sutton DG; Preston T; Guthrie AJ
    Equine Vet J Suppl; 2012 Dec; (43):62-7. PubMed ID: 23447880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of topical 1% atropine sulfate on intraocular pressure in normal horses.
    Herring IP; Pickett JP; Champagne ES; Troy GC; Marini M
    Vet Ophthalmol; 2000; 3(2-3):139-143. PubMed ID: 11397296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic effects of a prolonged continuous infusion of ketamine in healthy horses.
    Elfenbein JR; Robertson SA; Corser AA; Urion RJ; Sanchez LC
    J Vet Intern Med; 2011; 25(5):1134-7. PubMed ID: 21781164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post traumatic keratouveitis in horses.
    Moore CP; Halenda RM; Grevan VL; Collins BK
    Equine Vet J; 1998 Sep; 30(5):366-72. PubMed ID: 9758092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
    Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
    Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of indwelling nasogastric intubation on gastric emptying of a liquid marker in horses.
    Cruz AM; Li R; Kenney DG; Monteith G
    Am J Vet Res; 2006 Jul; 67(7):1100-4. PubMed ID: 16817727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-butylscopolammonium bromide causes fewer side effects than atropine when assessing bronchoconstriction reversibility in horses with heaves.
    de Lagarde M; Rodrigues N; Chevigny M; Beauchamp G; Albrecht B; Lavoie JP
    Equine Vet J; 2014 Jul; 46(4):474-8. PubMed ID: 24423012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of topical and systemic atropine sulfate on intraocular pressure and pupil diameter in the normal canine eye.
    Kovalcuka L; Birgele E; Bandere D; Williams DL
    Vet Ophthalmol; 2015 Jan; 18(1):43-9. PubMed ID: 24428364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
    Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
    Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximum atropine dose without clinical signs or symptoms.
    Cooper J; Eisenberg N; Schulman E; Wang FM
    Optom Vis Sci; 2013 Dec; 90(12):1467-72. PubMed ID: 24076540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esthesiometric evaluation of corneal analgesia after topical application of 1% morphine sulfate in normal horses.
    Gordon E; Sandquist C; Cebra CK; Heidel J; Poulsen K; Schlipf JW
    Vet Ophthalmol; 2018 May; 21(3):218-223. PubMed ID: 28714189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corneal stromal abscesses in the horse: a review of 24 cases.
    Hendrix DV; Brooks DE; Smith PJ; Gelatt KN; Miller TR; Whittaker C; Pellicane C; Chmielewski N
    Equine Vet J; 1995 Nov; 27(6):440-7. PubMed ID: 8565941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL; Lu Q; Tan D; Chia A
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of treatment with a topical ophthalmic preparation of 1% nalbuphine solution on corneal sensitivity in clinically normal horses.
    Wotman KL; Utter ME
    Am J Vet Res; 2010 Feb; 71(2):223-8. PubMed ID: 20113231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.